# LEVOLEUCOVORIN CALCIUM
> **NDA208723** · New Drug Application · Sponsor: ACTAVIS LLC · Approved 2016-09-29
## Drug
- **FDA Application Number:** NDA208723
- **Application type:** New Drug Application
- **Brand name:** LEVOLEUCOVORIN CALCIUM
- **Generic name:** Levoleucovorin Calcium
- **Active ingredients:** LEVOLEUCOVORIN CALCIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** ACTAVIS LLC
- **First approval:** 2016-09-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208723)
---
*MORVS · CC0 1.0*